Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinfeng Luo

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Bioorganic Chemistry|May 20, 2019
Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitorsYuyang Ding, Fei Tang, Xiaoqian Xue, et al.
Journal of Medicinal Chemistry|October 16, 2013
Design, synthesis, and biological evaluation of 2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidinyl derivatives as new irreversible epidermal growth factor receptor inhibitors with improved pharmacokinetic propertiesShilin Xu, Tianfeng Xu, Lianwen Zhang, et al.
International Journal of Nanomedicine|September 13, 2017
EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancerYang Li, Yanhong Duo, Shiyun Bao, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2011
New thiazole carboxamides as potent inhibitors of Akt kinasesShaohua Chang, Zhang Zhang, Xiaoxi Zhuang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 9, 2023
Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD productionYuqi Li, Linkun Zhang, Junkui Jiao, et al.
ACS Medicinal Chemistry Letters|October 22, 2015
Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer AgentsYanmei Zhang, Micky D Tortorella, Jinxi Liao, et al.
Journal of Medicinal Chemistry|March 5, 2014
Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenibHuimin Cheng, Yu Chang, Lianwen Zhang, et al.
Nanomedicine (London, England)|August 8, 2018
Dual targeting delivery of miR-328 by functionalized mesoporous silica nanoparticles for colorectal cancer therapyYang Li, Yanhong Duo, Peng Zhai, et al.
European Journal of Medicinal Chemistry|December 9, 2017
Design, synthesis, and biological evaluation of novel highly selective polo-like kinase 2 inhibitors based on the tetrahydropteridin chemical scaffoldMei-Miao Zhan, Yang Yang, Jinfeng Luo, et al.
Journal of Translational Medicine|November 16, 2024
LRRC8A drives NADPH oxidase-mediated mitochondrial dysfunction and inflammation in allergic rhinitisLinghui Meng, Dingqian Hao, Yuan Liu, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Bioorganic Chemistry|May 20, 2019
Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitorsYuyang Ding, Fei Tang, Xiaoqian Xue, et al.
Journal of Medicinal Chemistry|October 16, 2013
Design, synthesis, and biological evaluation of 2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidinyl derivatives as new irreversible epidermal growth factor receptor inhibitors with improved pharmacokinetic propertiesShilin Xu, Tianfeng Xu, Lianwen Zhang, et al.
International Journal of Nanomedicine|September 13, 2017
EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancerYang Li, Yanhong Duo, Shiyun Bao, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2011
New thiazole carboxamides as potent inhibitors of Akt kinasesShaohua Chang, Zhang Zhang, Xiaoxi Zhuang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 9, 2023
Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD productionYuqi Li, Linkun Zhang, Junkui Jiao, et al.
ACS Medicinal Chemistry Letters|October 22, 2015
Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer AgentsYanmei Zhang, Micky D Tortorella, Jinxi Liao, et al.
Journal of Medicinal Chemistry|March 5, 2014
Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenibHuimin Cheng, Yu Chang, Lianwen Zhang, et al.
Nanomedicine (London, England)|August 8, 2018
Dual targeting delivery of miR-328 by functionalized mesoporous silica nanoparticles for colorectal cancer therapyYang Li, Yanhong Duo, Peng Zhai, et al.
European Journal of Medicinal Chemistry|December 9, 2017
Design, synthesis, and biological evaluation of novel highly selective polo-like kinase 2 inhibitors based on the tetrahydropteridin chemical scaffoldMei-Miao Zhan, Yang Yang, Jinfeng Luo, et al.
Journal of Translational Medicine|November 16, 2024
LRRC8A drives NADPH oxidase-mediated mitochondrial dysfunction and inflammation in allergic rhinitisLinghui Meng, Dingqian Hao, Yuan Liu, et al.
Pageof 6